Nordhealth AS

NORDH · Oslo Børs · Healthcare

26.40NOK +5.6%last day

Price as of 2 October 2026

The price over the past year, with dividends: −27.9%

Performance

1 month

+3.9%

1 year

−27.9%

3 years, per year

+3.2%

5 years, per year

−8.6%

Largest fall, 3 years

−52.3%

Below the peak now

−42.6%

Volatility, 1 year

65.7%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

3.4

Dividend yield

0.0%

Return on equity

−28.9%

Net margin

−29.9%

Market value

216 m USD

Quality, value and trend

Where Nordhealth stands against every Nordic stock today. 100 is best.

Quality55

Profitability and a sound balance sheet over time. Better than 55% of Nordic stocks.

Value16

The price measured against earnings, assets and cash flow. Better than 16% of Nordic stocks.

Trend40

The price development over the past year. Better than 40% of Nordic stocks.

Combined24

Quality, value and trend together. Better than 24% of Nordic stocks.

About Nordhealth

Nordhealth AS is a company in healthcare, listed on Oslo Børs. The share trades in NOK. It has around 450 employees.

Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, DACH, and internationally. Its products include Provet, a practice management software platform for veterinary clinics and enterprise groups, providing appointment scheduling, patient management, electronic health records, billing and invoicing, reporting and analytics, government compliance tools, communication features, inventory management, and workflow automation; Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychiatrists; EasyPractice, a PMS for therapists; and…

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis